Search

everythinglearnresearchcommunity

for

Search:↓

Overweight women with PCOS have higher levels of certain hormones that could indicate a higher risk of heart and metabolic problems.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Chromium salts may help with insulin sensitivity in PCOS, but more research is needed to confirm their overall effectiveness and safety.

High levels of fatty acids are linked to increased androgen production and inflammation in women with PCOS, which may affect IVF outcomes.

Orlistat helped reduce weight and testosterone in obese women with PCOS but did not significantly affect other androgens or cholesterol levels.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

Vegan collagen builder improves hair growth, skin smoothness, and reduces wrinkles and pain.

Men with common hair loss (AGA) are more likely to have metabolic syndrome, which increases heart disease risk. Early screening could help prevent heart disease. More research is needed to understand this relationship better.

Adding anti-Müllerian hormone to PCOS criteria lowers the number of women diagnosed.

Indian women with PCOS may need different ultrasound criteria for diagnosis than current standards.

Obese people have more skin problems like stretch marks and infections, which get worse with higher obesity levels.

Hair loss is common in women with PCOS and is linked to symptoms like acne and excess hair but not to worse metabolic health.

PCOS is a complex condition in women that can lead to health issues, and lifestyle changes are the best management approach.

Isotretinoin improves severe acne without changing androgen or insulin levels but may increase body weight and triglycerides.

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

Shorter CAG repeats in a specific gene may increase male hormone activity and symptoms like acne and excess hair in women with PCOS.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Eating cream can increase ovarian androgen production in women with Polycystic Ovary Syndrome, which is not related to obesity.

PCOS may be influenced by factors in the blood, not just the ovaries.

Postmenopausal ovary stromal cells have a unique makeup and limited steroid production, suggesting androgens come from the adrenal gland.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

Researchers created a simple tool to predict bladder blockage from prostate enlargement using urine flow rate and prostate volume.

Normal-range ALT levels can indicate metabolic and hormonal imbalances in young women.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

While PCOS might increase the risk of heart disease, there's not strong evidence to prove it causes earlier heart problems.

A woman's high testosterone levels and related symptoms improved after ovary removal surgery.

Hair loss in women linked to higher sexual dysfunction risk.

Nourkrin® with Marilex® may significantly increase hair growth and alopecia could be an early sign of metabolic syndrome.

Different parts of the body's fat tissue have unique cell types and characteristics, which could help treat chronic wounds.